A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck
Titel:
A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck
Auteur:
MacDonald, G. C. Rasamoelisolo, M. Entwistle, J. Cuthbert, W. Kowalski, M. Spearman, Maureen A. Glover, N.